UBS Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.5M | Buy |
547,195
+191,877
| +54% | +$33.1M | 0.02% | 1112 |
|
|
2025
Q4 | $64.9M | Buy |
355,318
+142,867
| +67% | +$19.9M | 0.01% | 1367 |
|
|
2025
Q3 | $25.8M | Sell |
212,451
-383,004
| -64% | -$43.1M | 0.01% | 2285 |
|
|
2025
Q2 | $62.2M | Buy |
595,455
+306,808
| +106% | +$32.5M | 0.01% | 1313 |
|
|
2025
Q1 | $33.7M | Buy |
288,647
+141,300
| +96% | +$16.1M | 0.01% | 1843 |
|
|
2024
Q4 | $12.5M | Buy |
147,347
+99,585
| +209% | +$9.16M | ﹤0.01% | 2819 |
|
|
2024
Q3 | $4.29M | Buy |
47,762
+8,058
| +20% | +$703K | ﹤0.01% | 3233 |
|
|
2024
Q2 | $3.2M | Sell |
39,704
-21,616
| -35% | -$1.6M | ﹤0.01% | 3285 |
|
|
2024
Q1 | $4.89M | Buy |
61,320
+21,195
| +53% | +$1.78M | ﹤0.01% | 2997 |
|
|
2023
Q4 | $3.19M | Buy |
40,125
+7,341
| +22% | +$491K | ﹤0.01% | 3288 |
|
|
2023
Q3 | $2.29M | Buy |
32,784
+18,205
| +125% | +$1.36M | ﹤0.01% | 3310 |
|
|
2023
Q2 | $1.05M | Sell |
14,579
-1,692
| -10% | -$125K | ﹤0.01% | 4198 |
|
|
2023
Q1 | $1M | Buy |
16,271
+3,214
| +25% | +$211K | ﹤0.01% | 4095 |
|
|
2022
Q4 | $1.01M | Sell |
13,057
-5,244
| -29% | -$313K | ﹤0.01% | 4064 |
|
|
2022
Q3 | $817K | Buy |
18,301
+3,914
| +27% | +$196K | ﹤0.01% | 3921 |
|
|
2022
Q2 | $551K | Sell |
14,387
-2,004
| -12% | -$63.4K | ﹤0.01% | 4195 |
|
|
2022
Q1 | $678K | Buy |
16,391
+13,357
| +440% | +$414K | ﹤0.01% | 4454 |
|
|
2021
Q4 | $114K | Sell |
3,034
-6,312
| -68% | -$232K | ﹤0.01% | 6187 |
|
|
2021
Q3 | $308K | Sell |
9,346
-1,836
| -16% | -$71.5K | ﹤0.01% | 5025 |
|
|
2021
Q2 | $754K | Buy |
11,182
+1,738
| +18% | +$104K | ﹤0.01% | 4411 |
|
|
2021
Q1 | $535K | Buy |
9,444
+530
| +6% | +$37.3K | ﹤0.01% | 4815 |
|
|
2020
Q4 | $726K | Sell |
8,914
-4,539
| -34% | -$339K | ﹤0.01% | 4275 |
|
|
2020
Q3 | $959K | Sell |
13,453
-3,712
| -22% | -$289K | ﹤0.01% | 3676 |
|
|
2020
Q2 | $1.41M | Sell |
17,165
-3,792
| -18% | -$292K | ﹤0.01% | 3203 |
|
|
2020
Q1 | $1.23M | Sell |
20,957
-23,463
| -53% | -$1.91M | ﹤0.01% | 3172 |
|
|
2019
Q4 | $4.59M | Sell |
44,420
-1,322
| -3% | -$53.4K | ﹤0.01% | 2676 |
|
|
2019
Q3 | $926K | Buy |
45,742
+42,377
| +1,259% | +$1.09M | ﹤0.01% | 4031 |
|
|
2019
Q2 | $86K | Buy |
3,365
+1,530
| +83% | +$30.7K | ﹤0.01% | 5481 |
|
|
2019
Q1 | $26K | Buy |
+1,835
| New | +$17K | ﹤0.01% | 6055 |
|
|
2018
Q3 | – | Sell |
-279
| Closed | -$1K | – | 7962 |
|
|
2018
Q2 | $1K | Buy |
+279
| New | +$865 | ﹤0.01% | 7805 |
|
|
2017
Q4 | – | Sell |
-240
| Closed | -$1K | – | 7830 |
|
|
2017
Q3 | $1K | Sell |
240
-1,142
| -83% | -$6.13K | ﹤0.01% | 7556 |
|
|
2017
Q2 | $8K | Buy |
1,382
+1,113
| +414% | +$4.66K | ﹤0.01% | 6896 |
|
|
2017
Q1 | $1K | Sell |
269
-1,481
| -85% | -$7.08K | ﹤0.01% | 7401 |
|
|
2016
Q4 | $12K | Buy |
+1,750
| New | +$12.3K | ﹤0.01% | 6805 |
|
|
2016
Q3 | – | Sell |
-937
| Closed | -$7K | – | 7664 |
|
|
2016
Q2 | $7K | Sell |
937
-11,018
| -92% | -$101K | ﹤0.01% | 6958 |
|
|
2016
Q1 | $103K | Buy |
+11,955
| New | +$110K | ﹤0.01% | 4957 |
|
Other funds holding AXSM
VPM
VCM
DTC
